Literature DB >> 12144147

The resurgence of disease: social and historical perspectives on the 'new' tuberculosis.

Matthew Gandy1, Alimuddin Zumla.   

Abstract

The resurgence of tuberculosis is one of the most serious global public health challenges of the twenty-first century. This paper argues that the decline of tuberculosis since the nineteenth century is far better understood than its resurgence over the last twenty years. It is suggested that insights gained from the historical study of disease may provide a better analytical framework for understanding the contemporary dynamics of disease epidemiology than the current emphasis on the bio-medical and behavioural characteristics of individual patients. It is concluded that tuberculosis research requires a combination of advances in bio-medical knowledge with a broader understanding of the evolving relationship between disease and modern societies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144147     DOI: 10.1016/s0277-9536(01)00176-9

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  14 in total

1.  Tuberculosis 2004: challenges and opportunities.

Authors:  Jeffrey Glassroth
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

Review 2.  Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.

Authors:  Nora Engel; Eleanor A Ochodo; Perpetua Wanjiku Karanja; Bey-Marrié Schmidt; Ricky Janssen; Karen R Steingart; Sandy Oliver
Journal:  Cochrane Database Syst Rev       Date:  2022-04-26

3.  The economic divide and tuberculosis. Tuberculosis is not just a medical problem, but also a problem of social inequality and poverty.

Authors:  Paul D van Helden
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

4.  Infection of the Invisible: Impressions of a Tuberculosis Intervention Program for Migrants in Istanbul.

Authors:  Yesim Yasin; Kristen Biehl; Maral Erol
Journal:  J Immigr Minor Health       Date:  2015-10

5.  To End TB, First-Ever High-Level Meeting on Tuberculosis Must Address Stigma.

Authors:  Amrita Daftary; Ellen M H Mitchell; Michael J A Reid; Endalkachew Fekadu; Eric Goosby
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

Review 6.  New small-molecule synthetic antimycobacterials.

Authors:  Lluis Ballell; Robert A Field; Ken Duncan; Robert J Young
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  Health services performance for TB treatment in Brazil: a cross-sectional study.

Authors:  Tereza Cs Villa; Antônio Ruffino-Netto; Lucia M Scatena; Rubia Lp Andrade; Maria Ef Brunello; Jordana A Nogueira; Pedro F Palha; Lenilde D Sá; Marluce Ma Assis; Silvia Hf Vendramini; Aline A Monroe; Ricardo A Arcêncio; Tiemi Arakawa
Journal:  BMC Health Serv Res       Date:  2011-09-28       Impact factor: 2.655

8.  Patient and community experiences of tuberculosis diagnosis and care within a community-based intervention in Ethiopia: a qualitative study.

Authors:  Olivia Tulloch; Sally Theobald; Fukushi Morishita; Daniel G Datiko; Girum Asnake; Tadesse Tesema; Habiba Jamal; Paulos Markos; Luis E Cuevas; Mohammed A Yassin
Journal:  BMC Public Health       Date:  2015-02-25       Impact factor: 3.295

9.  Role of diabetes in the prognosis and therapeutic outcome of tuberculosis.

Authors:  Syed Azhar Syed Suleiman; Daud M Ishaq Aweis; Ali Jimale Mohamed; Abdul Razakmuttalif; Mohamed A A Moussa
Journal:  Int J Endocrinol       Date:  2012-04-18       Impact factor: 3.257

10.  Asymptomatic Helminth Infection in Active Tuberculosis Is Associated with Increased Regulatory and Th-2 Responses and a Lower Sputum Smear Positivity.

Authors:  Ebba Abate; Meseret Belayneh; Jonna Idh; Ermias Diro; Daniel Elias; Sven Britton; Abraham Aseffa; Olle Stendahl; Thomas Schön
Journal:  PLoS Negl Trop Dis       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.